These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt, with results 2007-000728-41 A phase I/II trial testing nelfinavir, an inhibitor of Akt signaling, in combination with preoperative chemoradiotherapy in patients with locally advanced rectal cancer not-yet-due
Exempt 2008-001078-34 Phase I/II study for patients with newly diagnosed glioblastoma testing nelfinavir in combination with radiotherapy and concomitant and adjuvant temozolomide not-yet-due
Exempt, with results 2009-014772-22 Chloroquine as an anti-autophagy drug in small cell lung cancer (SCLC) patients: A phase I trial to be followed by a phase II trial. not-yet-due
Completed, but no date, and reported results Terminated 2010-023120-24 Nitroglycerin's effect on perfusion and hypoxia in human non small cell lung cancer: proof of principle, a phase II trial bad-data
Reported results 2011-001812-80 Non invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer. 2015-08-25 due-trials
Not reported Terminated 2014-000224-17 Non invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Cervix Cancer. 2018-01-25 due-trials
Completed, but no date Terminated 2014-003873-41 Non invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trial bad-data